watch cnbc's full interview with novartis ceo vas narasimhan
Published 4 years ago • 4.7K plays • Length 7:51Download video MP4
Download video MP3
Similar videos
-
4:43
novartis ceo: our leukemia drug scemblix is a potential $3 billion plus medicine
-
3:47
novartis ceo: demand has surged for therapeutics
-
3:43
novartis ceo vas narasimhan on the latest research on a breast cancer drug
-
4:19
focus remains on r&d to drive growth of blockbuster drugs, says novartis ceo
-
3:45
novartis not joining the 'frenzy' of weight loss drugs, ceo says
-
1:15
novartis ceo says fda's extended approval of breast cancer drug is a 'landmark' for the firm
-
6:12
novartis ceo: expect continued growth in 2023
-
3:42
novartis ceo vasant narasimhan on building trust with society
-
9:32
vasant narasimhan novartis ceo on transforming pharma industry
-
4:27
vas narasimhan and author dan pink talk culture and leadership
-
4:22
we'll remain in goldilocks zone 'a little bit more', says universa investment's mark spitznagel
-
3:07
novartis ceo on the impact of the u.s. election for pharma
-
4:56
'we have reached an endemic environment with covid,' says novartis ceo
-
4:22
novartis ceo on new cancer therapy programs
-
5:53
novartis expects 'strong momentum' going into second half, says ceo vasant narasimhan
-
7:36
"i don’t feel pressure from shareholders," says novartis ceo vas narasimhan
-
12:38
health care in a post-pandemic world with vas narasimhan novartis at cnbc evolve global summit 2021
-
4:16
novartis ceo vas narasimhan: our medicines are starting to take market share and deliver on promises
-
7:51
novartis ceo on how yoga & lessons from his grandparents help in taking big professional decisions
-
22:59
089 - vas narasimhan, ceo of novartis: transforming standards of patient care
-
4:54
novartis ceo: confident about continued sales growth for rest of year
-
21:49
novartis ceo narasimhan on covid, treatments